Table 4 Treatment and outcomes
| Â | PM | DM | CADM | ||
|---|---|---|---|---|---|
| Â | ILD (N = 11) | No ILD (N = 12) | ILD (N = 11) | No ILD (N = 13) | ILD (N = 15) |
Initial immunosuppressive therapy | Â | Â | Â | Â | Â |
  Prednisone + Cyclosporine + Cyclophosphamide | 1 | 0 | 1 | 0 | 6 |
  Prednisone + Cyclosporine | 1 | 0 | 2 | 0 | 6 |
  Prednisone + Cyclophosphamide | 0 | 0 | 1 | 0 | 1 |
  Prednisone + Azathioprine | 1 | 3 | 1 | 2 | 0 |
  Prednisone + Tacrolimus | 0 | 0 | 1 | 0 | 0 |
  Prednisone + Methotrexate | 0 | 2 | 0 | 1 | 0 |
  Prednisone | 8 | 5 | 4 | 9 | 1 |
  No therapy | 0 | 2 | 1 | 1 | 1 |
Treatment for maligancy | Â | Â | Â | Â | Â |
  Surgical resection | 0 | 1 | 1 | 4 | 0 |
  Chemotherapy | 0 | 2 | 1 | 4 | 0 |
Outcome | Â | Â | Â | Â | Â |
  Death (number of patients) | 1 | 3 | 4 | 5 | 5 |
  Days from first visit to death | 267 | 1520 (1179–2125) | 376 (232–738) | 122 (32–1071) | 33 (27–41) |
  Cause of death | Renal failure | Aspiration pneumonia | ILD (2) | Aspiration pneumonia (3) | ILD (4) |
| Â | Hypoglycemia | Breast cancer | Malignant lymphoma | Extradural hematoma | |
| Â | Sepsis | Brainstem infarction | lung cancer | Â | |